393 related articles for article (PubMed ID: 31315684)
21. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M
Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
[TBL] [Abstract][Full Text] [Related]
22. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.
Sangueza M; Plaza JA
J Am Acad Dermatol; 2013 Jul; 69(1):112-9. PubMed ID: 23541598
[TBL] [Abstract][Full Text] [Related]
23. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
24. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
[TBL] [Abstract][Full Text] [Related]
25. Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature.
Yang YQ; Fan L; Wang L; Xu J; Zhang R; Ge Z; Li JY; Xu W
Int J Clin Exp Pathol; 2014; 7(9):6403-8. PubMed ID: 25337300
[TBL] [Abstract][Full Text] [Related]
26. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
27. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.
López de Cáceres CVB; Rodrigues-Fernandes CI; Rendón Henao J; Morais TML; Soares CD; de Almeida OP; Fonseca FP; Delgado-Azañero W
J Oral Pathol Med; 2021 Jul; 50(6):530-539. PubMed ID: 34097774
[TBL] [Abstract][Full Text] [Related]
28. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
Garzón E; Dávila-Rodríguez JJ
Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
[TBL] [Abstract][Full Text] [Related]
29. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.
Grześk E; Kołtan S; Dąbrowska A; Urbańczyk A; Małdyk J; Małkowski B; Bogiel T; Dębski R; Czyżewski K; Wysocki M; Styczyński J
Front Immunol; 2022; 13():915986. PubMed ID: 35990691
[TBL] [Abstract][Full Text] [Related]
30. Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature.
Wang M; Wang S; Yang QP; Liu YM; Gao LM; Sun H; Liu WP
Diagn Pathol; 2013 May; 8():72. PubMed ID: 23635342
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
32. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder.
Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L
Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959
[TBL] [Abstract][Full Text] [Related]
33. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
34. Hydroa Vacciniforme-Like T-Cell Lymphoma: A Further Brazilian Case.
Miranda MFR; Santos JEBD; Müller SFR; Bittencourt MJS; Brito AC; Barros Junior JNDS; Xerfan EMS
Am J Dermatopathol; 2018 Mar; 40(3):201-204. PubMed ID: 28248720
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
[TBL] [Abstract][Full Text] [Related]
36. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
[TBL] [Abstract][Full Text] [Related]
37. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
38. Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells.
Hirai Y; Iwatsuki K; Takahashi T; Miyake T; Nakagawa Y; Tanimoto S; Kawakami Y; Morizane S
Int J Hematol; 2023 Jul; 118(1):54-64. PubMed ID: 37133637
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous hydroa vacciniforme-like lymphoma with indolent clinical course: report of two cases and review of literature.
Li Y; Chen XH; Tian XY; Li B; Li Z
Int J Surg Pathol; 2013 Apr; 21(2):161-8. PubMed ID: 22807582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]